Jerry S Lanchbury is Chief Scientific Officer of MYRIAD GENETICS INC. Currently has a direct ownership of 264,324 shares of MYGN, which is worth approximately $4.09 Million. The most recent transaction as insider was on Oct 09, 2021, when has been sold 10,811 shares (Common Stock) at a price of $30.88 per share, resulting in proceeds of $333,844. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 264K
0% 3M change
0% 12M change
Total Value Held $4.09 Million

JERRY S LANCHBURY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 09 2021
SELL
Payment of exercise price or tax liability
$333,844 $30.88 p/Share
10,811 Reduced 3.93%
264,324 Common Stock
Sep 26 2021
SELL
Payment of exercise price or tax liability
$121,015 $33.31 p/Share
3,633 Reduced 1.3%
275,135 Common Stock
Sep 25 2021
SELL
Payment of exercise price or tax liability
$324,673 $33.31 p/Share
9,747 Reduced 3.38%
278,768 Common Stock
Sep 23 2021
SELL
Open market or private sale
$7,012 $35.06 p/Share
200 Reduced 0.07%
288,515 Common Stock
Sep 21 2021
BUY
Grant, award, or other acquisition
-
58,398 Added 16.82%
288,715 Common Stock
Aug 25 2021
SELL
Payment of exercise price or tax liability
$77,731 $34.81 p/Share
2,233 Reduced 0.96%
230,317 Common Stock
Aug 24 2021
SELL
Open market or private sale
$1,067,100 $35.57 p/Share
30,000 Reduced 11.43%
232,550 Common Stock
Aug 24 2021
BUY
Exercise of conversion of derivative security
$812,100 $27.07 p/Share
30,000 Added 10.25%
262,550 Common Stock
Aug 23 2021
SELL
Open market or private sale
$1,766,000 $35.32 p/Share
50,000 Reduced 17.7%
232,550 Common Stock
Aug 23 2021
BUY
Exercise of conversion of derivative security
$1,353,500 $27.07 p/Share
50,000 Added 15.5%
272,550 Common Stock
Aug 05 2021
SELL
Open market or private sale
$1,003,963 $35.57 p/Share
28,225 Reduced 10.82%
232,550 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$764,051 $27.07 p/Share
28,225 Added 9.77%
260,775 Common Stock
Aug 04 2021
SELL
Open market or private sale
$1,770,500 $35.41 p/Share
50,000 Reduced 17.7%
232,550 Common Stock
Aug 04 2021
BUY
Exercise of conversion of derivative security
$1,353,500 $27.07 p/Share
50,000 Added 16.99%
244,325 Common Stock
Aug 03 2021
SELL
Open market or private sale
$1,713,500 $34.27 p/Share
50,000 Reduced 17.7%
232,550 Common Stock
Aug 03 2021
BUY
Exercise of conversion of derivative security
$1,269,000 $25.38 p/Share
50,000 Added 17.44%
236,720 Common Stock
Jul 13 2021
SELL
Open market or private sale
$1,459,907 $33.72 p/Share
43,295 Reduced 15.7%
232,550 Common Stock
Jul 13 2021
BUY
Exercise of conversion of derivative security
$1,146,885 $26.49 p/Share
43,295 Added 13.71%
272,550 Common Stock
Jul 12 2021
SELL
Open market or private sale
$1,677,500 $33.55 p/Share
50,000 Reduced 17.7%
232,550 Common Stock
Jul 12 2021
BUY
Exercise of conversion of derivative security
$1,324,500 $26.49 p/Share
50,000 Added 16.9%
245,845 Common Stock
Jul 09 2021
SELL
Open market or private sale
$1,626,000 $32.52 p/Share
50,000 Reduced 17.7%
232,550 Common Stock
Jul 09 2021
BUY
Exercise of conversion of derivative security
$1,207,500 $24.15 p/Share
50,000 Added 16.65%
250,242 Common Stock
Jul 07 2021
SELL
Open market or private sale
$1,038,379 $32.14 p/Share
32,308 Reduced 12.2%
232,550 Common Stock
Jul 07 2021
BUY
Exercise of conversion of derivative security
$855,839 $26.49 p/Share
32,308 Added 12.11%
234,434 Common Stock
Jun 28 2021
SELL
Open market or private sale
$220,573 $32.38 p/Share
6,812 Reduced 2.85%
232,550 Common Stock
JSL

Jerry S Lanchbury

Chief Scientific Officer
Salt Lake City, UT

Track Institutional and Insider Activities on MYGN

Follow MYRIAD GENETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN